NCT00683618 - Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia | Biotech Hunter

Enrollment

934

Participants

Timeline

Start Date

May 31, 2008

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions

Hypercholesterolemia

Interventions

DRUG

Rosuvastatin

Capsule/Tablet, oral, qd, 6 or 12 weeks

DRUG

Atorvastatin

Capsule/Tablet, 10mg, oral, qd, 6 weeks

Trial Locations (6)

Research Site, Wuhan

Research Site, Changsha

Research Site, Shenyang

Research Site, Beijing

Research Site, Shanghai

Research Site, Tianjin